| Literature DB >> 34923449 |
Hairil Rizal Abdullah1, Sean Shao Wei Lam2, Boon Yew Ang3, Ahmadreza Pourghaderi4, Francis Ngoc Hoang Long Nguyen5, David Bruce Matchar6, Hiang Khoon Tan7, Marcus Eng Hock Ong8.
Abstract
OBJECTIVE: To develop a 2-stage discrete events simulation (DES) based framework for the evaluation of elective surgery cancellation strategies and resumption scenarios across multiple operational outcomes.Entities:
Keywords: Agile resource planning; COVID-19; Discrete events simulation; Healthcare resource allocation; OR resource management
Year: 2021 PMID: 34923449 PMCID: PMC8674476 DOI: 10.1016/j.ijmedinf.2021.104665
Source DB: PubMed Journal: Int J Med Inform ISSN: 1386-5056 Impact factor: 4.730
Fig. 1Data cleaning process for the unsupervised cluster analysis.
Fig. 2Flowchart for the fuzzy clustering algorithm.
Fig. 3Timeline of events for the surgical scheduling process.
Fig. 4UML diagram depicting inter-twined relationships and information flows across various stakeholders and subsystems.
Monthly Surgery Loads across OR locations from 1 Jan 2019/2020 to 31 May 2019/2020.
| Location | 2019 | 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | Mar | Apr | May | Jan | Feb | Mar | Apr | May | |
| ASC | 433 | 348 | 499 | 455 | 440 | 329 | 0 | 265 | 183 | 85 |
| MOT | 1404 | 1222 | 1515 | 1541 | 1544 | 1326 | 1111 | 1179 | 1104 | 906 |
| URO | 220 | 151 | 198 | 226 | 243 | 199 | 56 | 1 | 5 | 6 |
| Others | 92 | 74 | 92 | 92 | 88 | 147 | 145 | 174 | 151 | 94 |
Fig. 5(a) Cluster identification using the Gap Statistics; (b) Descriptive statistics of 4 clusters.
Summary Statistics for the Cluster Analysis based on the LOS statistics.
| Statistic | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | |
|---|---|---|---|---|---|
| Length of Stay Statistics | Minimum | 1 | 1 | 1 | 1 |
| 1st Quartile | 2 | 4 | 5 | 14 | |
| 3 | 8 | 35 | |||
| Mean | 5.02 | 13.65 | 25.87 | 46.72 | |
| Standard Dev | 5.79 | 18.00 | 33.1 | 45.6 | |
| 3rd Quartile | 6 | 16 | 35 | 62 | |
| Maximum | 132 | 257 | 261 | 301 | |
Year-on-Year (YOY) Comparison of Surgery Loads.
| Cluster | Year | Jan | Feb | Mar | Apr | May |
|---|---|---|---|---|---|---|
| C1 | 2019 | 1252 | 1173 | 1556 | 1586 | 1538 |
| 2020 | 1244 | 696 | 911 | 669 | 477 | |
| C2 | 2019 | 261 | 282 | 335 | 337 | 335 |
| 2020 | 317 | 283 | 290 | 299 | 285 | |
| C3 | 2019 | 94 | 101 | 112 | 120 | 131 |
| 2020 | 123 | 117 | 165 | 177 | 127 | |
| C4 | 2019 | 84 | 115 | 129 | 105 | 117 |
| 2020 | 152 | 126 | 128 | 177 | 118 | |
Fig. 6Breakdown of the reduction of surgical loads across the 4 clusters.
Top 10 surgeries in Cluster 1 and 2.
| Procedure Code | Cluster | Description |
|---|---|---|
| SJ802T | 1 | Thyroid, Various Lesions, Hemithyroidectomy/Partial Thyroidectomy |
| SI725U | 1 | Uterus/cervix, Hysteroscopy, Diagnostic, D&C |
| SF820A | 1 | Abdominal Wall, Inguinal/Femoral Hernia, Bilateral Herniorrhaphy (MIS/open) |
| SH830P | 1 | Prostate Gland, Various Lesions, Radical Prostatectomy (MIS/open) |
| SM705T | 1 | Tonsils, Various Lesions, Removal with/without Adenoidectomy |
| SA702S | 1 | Skin and Subcutaneous Tissue, Tumor/Cyst/Ulcer/Scar, Excision biopsy, Lesion size more than 15 mm in diameter |
| SJ803T | 1 | Thyroid, Various Lesions, Total/Subtotal Thyroidectomy |
| SM714N | 1 | Nose, Various Lesions (turbinates), turbinectomy/turbinoplasty/Submucous Resection (with or without endoscopes) |
| SH835P | 1 | Prostate Gland, Various Lesions, Saturation Prostate Biopsy |
| SM724N | 1 | Nose, Various Lesions, Septoplasty/Submucous Resection |
| SB810K | 2 | Knee, Various Lesions, Primary Total Joint Replacement (Unilateral), open/MIS/navigated |
| SF819A | 2 | Abdominal Wall, Inguinal/Femoral Hernia, Unilateral Herniorrhaphy (MIS/open) |
| SB716K | 2 | Knee, Various Lesions, Primary Total Joint Replacement (Unilateral) with augmentation, requiring extra implants or bone grafts, open/MIS/navigated |
| SF801G | 2 | Gallbladder, Various Lesions, Cholecystectomy (open or lap) |
| SA824B | 2 | Breast, Tumor (malignant), Simple Mastectomy with Axiliary Clearance, with/without Sentinel Node Biopsy |
| SA827B | 2 | Breast, Tumor (malignant), Simple Mastectomy with Sentinel Node Biopsy/Axiliary Node Sampling |
| SG700U | 2 | Ureter, Cystoscopy and insertion of double J stent |
| SF701C | 2 | Colon, Anterior Resection (OpenMIS) |
| SC701L | 2 | Lung, Various lesions, Pneumonectomy/Lobectomy, MIS |
| SG800U | 2 | Ureter, Ureteroscopy and lithotripsy |
| SF708B | 3 | Bile Duct, Endoscopic Retrograde Cholangiopancreatography (ERCP) with sphincerotomy/removal of stone/insertion of biliary stent |
| SD812H | 3 | Heart, Coronary Disease, Coronary Artery Bypass Graft (Open) |
| SB808S | 3 | Spine, Deformities, Corrective Osteotomy – With/Without Computer Navigation |
| SF803C | 3 | Colon, Various Lesions, Right/Left Hemicolectomy (MIS/open) |
| SD712B | 3 | Blood vessels, Vascular System, Various Lesions, Insertion of Tenckhoff Catheter |
| SD731H | 3 | Heart, Valve (Repair/Replacement) - 1 Valve |
| SF702C | 3 | Colon, Colonoscopy (diagnostic), fibreoptic with/without biopsy |
| SB729S | 3 | Spine, Various Lesions, Decompression, Spinal Instrumentation, Multiple Levels |
| SD721A | 3 | Artery, Stenosis/Occlusion, Percutaneous Transluminal Angioplasty (PTA), Simple |
| SF813L | 3 | Liver, Various Lesions, Partial Lobectomy/Segmental Resection (open or lap) |
| SA811S | 4 | Skin and Subcutaneous Tissue, Deep greater than 3 cm/Extensive Contaminated Wound, Debridement |
| SF701I | 4 | Intestine/Stomach, Upper GI endoscopy with/without biopsy |
| SD720A | 4 | Artery, Stenosis/Occlusion, Percutaneous Transluminal Angioplasty (PTA), Difficult (eg subintimal PTA, below knee PTA) |
| SG713B | 4 | Bladder, Cystoscopy, with or without biopsy |
| SA853S | 4 | Skin and Subcutaneous Tissue, Wound, Debridement < 3 cm |
| SF808A | 4 | Abdominal Cavity, Various Lesions, Exploratory Laparotomy (MIS/open) |
| SD821A | 4 | Artery, Various Lesions, Arterio-venuous Fistula Creation |
| SK708B | 4 | Brain, Intracerebral Tumor, Biopsy and/or Decompression/Removal via Craniotomy, Complex |
| SF807E | 4 | Esophagus/Intestine/Stomach, Upper GI endoscopy with insertion of Prosthesis (e.g. insertion of Celestin Tube/complicated Polypectomy) |
| SF809P | 4 | Pancreas, Various Lesions, Whipple Operation/Total Pancreatectomy |
Fig. 7Comparison of Bed Demands and OR Utilization across 4 strategies and full resumption for: (a) Recovery of Bed Demands to BAU; (b) OR Utilization before surgery, during reduction and during resumption.
Fig. 8Comparison of Time to Event measures across 4 strategies and full resumption with 95% confidence intervals for: (a) Peak Bed During Resumption (b) Peak OR Utilization (c) Convergence Time to BAU for Bed Demands (d) Convergence Time to BAU for OR Utilization.
Results from the simulation model across the various outcome measures.
| Policy | Resumption Strategy | Range of Bed Demands During Resumption | Range of OR Utilization During Resumption | Range of Peak Wait Times to Surgery During Resumption | Time to Event | ||
|---|---|---|---|---|---|---|---|
| Time to Peak Bed During Resumption | Converge to BAU for Bed Demands | Converge to BAU for OR Utilization | |||||
| Full Resumption | Strategy 0 | 485.0–504.3 | 94.2% −96.2% | 74.3–108.2 | 154.9 (77.5) | 241.0 (45.7) | 199.7 (13.6) |
| Sequential Resumption | Strategy 1 | 470.9–496.1 | 92.1%–95.6% | 41.8–145.5 | 152.4 (94.5) | 266.6 (64.6) | 242.5 (33.7) |
| Strategy 2 | 482.7–500.6 | 92.0%–96.3% | 56.1–119.9 | 149.8 (66.1) | 223.5 (53.3) | 213.7 (45.6) | |
| Strategy 3 | 472.9–501.4 | 91.3%–96.2% | 75.2–145.7 | 138.6 (67.2) | 271.0 (60.5 | 220.1 (35.8) | |
| Strategy 4 | 477.5–497.3 | 91.4%–95.7% | 36.8–116.4 | 180.8 (80.3) | 243.8 (49.7) | 210.1 (42.9) | |
^ Lower bound is based on conservative estimate across 2 weeks before and after peak demands. Upper bound is the absolute maximum bed demand/OR Utilization.
Fig. 9Decision support dashboard for monitoring the resumption of surgical services during COVID-19.